Tempest Therapeutics Stock Investor Sentiment
| TPST Stock | USD 0.81 0.01 1.22% |
Slightly above 67% of Tempest Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tempest Therapeutics suggests that many traders are alarmed. Tempest Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Tempest Therapeutics' earnings reports, geopolitical events, and overall market trends.
Tempest |
Tempest Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Tempest Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Tempest Therapeutics that are available to investors today. That information is available publicly through Tempest media outlets and privately through word of mouth or via Tempest internal channels. However, regardless of the origin, that massive amount of Tempest data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tempest Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tempest Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tempest Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tempest Therapeutics alpha.
Tempest Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Nicholas Maestas of 200000 shares of Tempest Therapeutics at 0.86 subject to Rule 16b-3 | 01/02/2025 |
2 | Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | 01/06/2025 |
3 | Acquisition by Whiting Samuel of 1700 shares of Tempest Therapeutics at 4.8048 subject to Rule 16b-3 | 01/17/2025 |
4 | Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635 | 02/07/2025 |
5 | Tempest gets fast track designation from FDA for amezalpat | 02/10/2025 |
6 | Acquisition by Pellizzari Christine A of 16000 shares of Tempest Therapeutics at 3.03 subject to Rule 16b-3 | 02/28/2025 |
7 | Tempest Therapeutics Stock Price Down 5.5 percent Time to Sell | 03/13/2025 |
Additional Tools for Tempest Stock Analysis
When running Tempest Therapeutics' price analysis, check to measure Tempest Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tempest Therapeutics is operating at the current time. Most of Tempest Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tempest Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tempest Therapeutics' price. Additionally, you may evaluate how the addition of Tempest Therapeutics to your portfolios can decrease your overall portfolio volatility.